The Asia-Pacific Forum on RNA Therapeutics and Vaccines (APFRTV 2026)
The Asia-Pacific Forum on RNA Therapeutics and Vaccines (APFRTV 2026) was successfully held on 25th September 2026 at the CS-Auditorium, South Asian University (SAU), New Delhi, bringing together 120 delegates comprising scientists, researchers, academicians, healthcare professionals, students, and experts from diverse fields of life sciences, biotechnology, medicine, and public health. Organized by the One Health India Organization (OHIO), New Delhi, in collaboration with the Faculty of Life Sciences and Biotechnology (FLSB), South Asian University, New Delhi, the forum was held under the theme: “Advancing RNA Science from Bench to Population Impact”. The conference provided an interdisciplinary platform for scientific exchange and discussion on emerging developments in RNA therapeutics, RNA vaccines, molecular medicine, biotechnology, and translational research. The Chief Guest, Dr. Neeta Kumar, Scientist F, ICMR, New Delhi & Prof. Kapil Sharma, Vice President, South Asian University formally inaugurated the conference. The inauguration ceremony was graced by: Prof. Rinkoo Devi Gupta, Dean, FLSB, South Asian University, Prof. Ritu Gaur, Vice President, South Asian University, Prof. Sudhanshu Vrati, Former Executive Director, Regional Centre for Biotechnology
Prof. (Dr.) K.K. Pandey, Ex. Sr. Professor & HOD, FoAy, IMS, BHU; BBIFCC Fellow & Advisor Dr. Birendra Kr. Yadav, BBIFCC – Convener & Chief Organizing Secretary, Dr. Yuba Raj Pokharel, South Asian University – Co-convener & Organizing Secretary and Dr. Sonam Dhamija, Convenor. The distinguished dignitaries highlighted the importance of interdisciplinary collaboration, innovation, research capacity building, and translating advances in RNA science into meaningful healthcare and public-health outcomes. APFRTV 2026 featured an extensive scientific programme bringing together experts and emerging researchers to discuss the rapidly developing landscape of RNA therapeutics and vaccines.The scientific sessions covered emerging research areas, technological innovations, therapeutic development, vaccine technologies, molecular medicine, and translational approaches. The programme encouraged scientific dialogue and provided opportunities for researchers and young scientists to exchange ideas and explore future collaborations. The conference featured both oral and poster presentation sessions, showcasing research and innovative work related to RNA science, therapeutics, vaccines, biotechnology, molecular biology, and allied areas. First, Second, and Third Position winners were selected and recognized for their scientific contributions and presentation quality. An Oral Presentation-First Position was also awarded.